Immutep (ASX: IMM) are global leaders in the understanding and development of therapeutics that relate to Lymphocyte Activation Gene-3 or “LAG-3” which is a cell surface molecule that plays a vital role in regulating the immune system. LAG-3 was discovered by our Chief Scientific Officer and Chief Medical Officer Dr. Frederic Triebel, putting Immutep at the forefront of immunotherapy drugs for cancer and autoimmune diseases.
Latest from Immutep (ASX: IMM) on LAG-3 and 2022 Outlook
The attached video covers biotech company Immutep's latest news on their Lymphocyte Activation Gene-3 (LAG-3) treatment and outlook for the coming 12 months.
- Published on December 15, 2021
- By Staff Writers
Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X
Recent Posts
- Tariff mayhem, Aus vulnerable from hit to global growth,...March 14, 2025
- Hot Stocks: Catalyst Metals, Cyclopharm, Tivan, Liontown...March 14, 2025
- Tin prices surge as Alphamin mine closure worsens supply...March 14, 2025
- Chinese stocks rally as policy optimism and foreign...March 14, 2025
- US tightens sanctions on Russian banks as ceasefire...March 14, 2025
All Categories
- Battery Technology (2)
- Biotechnology (101)
- brekkie wrap (74)
- Broker News (2466)
- Commodities (1680)
- Hydrogen (6)
- Lithium (106)
- Potash (11)
- Rare Earths (6)
- Renewables (35)
- Company (7)
- Corporate Connect Research (24)
- Currencies (42)
- Cryptocurrencies (28)
- daily special (55)
- David Bassanese (90)
- Economics (3084)
- ESG (117)
- Etfs (500)
- EV Space (128)
- Featured (42)
- FinTech (26)
- Fixed Interest (231)
- FNN Content (6112)
- Franklin Templeton (1)
- fresh grind (252)
- fundie guide (22)
- Funds (1422)
- Gavin Wendt (141)
- Greg Tolpigin (75)
- hot stocks (52)
- Infrastructure (28)
- Interest Rates (386)
- investor blend (43)
- IPOs (20)
- James Dunn (185)
- Kris Walesby (67)
- LICs (162)
- Marc Sinatra (4)
- market mocha (364)
- Market Reports Text (283)
- Markets (14003)
- Media (71)
- Noosa Mining Conference (29)
- Podcasts (1)
- Politics (53)
- Product Profiles (23)
- Property (225)
- Reports (511)
- Retail (254)
- round table (8)
- Shane Oliver (260)
- Shares (18215)
- Stocks of the Hour (300)
- sip & learn (23)
- sip and learn (23)
- Sponsored Content (32)
- Strategy (204)
- Super (36)
- table for two (22)
- Technical Analysis (5)
- Technology (419)
- The Week that Was (112)
- Tim Boreham (85)
- Uncategorized (157)
- Video (4332)
- Webinars (195)
- Weekly Wrap (831)